Evidence map›Paper›PMID 38223354›Full record

ArticleJournal of tropical medicine2024

Development of Deltamethrin-Laced Attractive Toxic Sugar Bait to Control

Sarita Kumar, Aarti Sharma, Roopa Rani Samal, Vaishali Verma, Ravinder Kumar Sagar, Shri Pati Singh, Kamaraju Raghavendra

Open access · goldAbstract read
In one paragraph

Article in Journal of tropical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sarita KumarDepartment of Zoology, Acharya Narendra Dev College, University of Delhi, Kalkaji, New Delhi 110 019, India.ORCID https://orcid.org/0000-0002-1066-3057
Aarti SharmaDepartment of Zoology, Acharya Narendra Dev College, University of Delhi, Kalkaji, New Delhi 110 019, India.ORCID https://orcid.org/0000-0003-2683-8904
Roopa Rani SamalDepartment of Zoology, Acharya Narendra Dev College, University of Delhi, Kalkaji, New Delhi 110 019, India.ORCID https://orcid.org/0000-0001-8268-3279
Vaishali VermaICMR-National Institute of Malaria Research, Sector 8, Dwarka, New Delhi 110 077, India.ORCID https://orcid.org/0000-0002-5843-4261
Ravinder Kumar SagarDepartment of Zoology, Acharya Narendra Dev College, University of Delhi, Kalkaji, New Delhi 110 019, India.ORCID https://orcid.org/0000-0002-5990-9070
Shri Pati SinghICMR-National Institute of Malaria Research, Sector 8, Dwarka, New Delhi 110 077, India.ORCID https://orcid.org/0000-0003-1573-005X
Kamaraju RaghavendraICMR-National Institute of Malaria Research, Sector 8, Dwarka, New Delhi 110 077, India.ORCID https://orcid.org/0000-0002-4098-7095
University of Delhi · INNational Institute of Malaria Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The attractive toxic sugar bait (ATSB) is a promising strategy for controlling mosquitoes at the adult stage. The strategy is based on the use of a combination of fruit juice, sugar, and a toxin in order to attract and kill the adult mosquitoes. The selection of the components and optimization of their concentrations is significant for the formulation of an effective ATSB. Methods: The present study formulated nine ATSBs and evaluated their efficacy against two laboratory strains (AND- Results: The ATSB formulations registered 8.33-97.44% mortality against AND- Conclusions: The ATSBs formulated with guava juice-ASB and deltamethrin (9 : 1) showed toxin dose-dependent toxicity by all the four strains of

Identifiers

PMID38223354
PMCPMC10787649
OpenAlexW4390635671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.